South Indian Bank Q1: PAT +17% YoY to ₹378 Cr as low provisions flatter a core slowdown

South Indian Bank posted consolidated net profit of ₹377.66 Cr for Q1 FY27, up 17.2% YoY from ₹322.17 Cr but down 7.3% sequentially from ₹407.40 Cr; standalone is effectively identical (₹377.63 Cr). Interest earned rose 11.2% YoY to ₹2,627.81 Cr, and the core engine was strong — net interest income climbed ~23% YoY to ~₹1,024.7 Cr, confirming the NIM-widening story management laid out on the Q4 concall as the book tilts to higher-yielding retail/MSME. EPS was ₹1.44 versus ₹1.23 a year ago.

The quality of the print is the real story. Operating profit actually FELL ~12% YoY to ₹591.84 Cr, because other income collapsed 39% YoY to ₹379.49 Cr (treasury segment result dropped from ₹203.69 Cr to ₹87.46 Cr as last year's investment gains did not repeat). PAT still grew only because provisions and contingencies fell 65% YoY — from ₹239.26 Cr to just ₹84.34 Cr. Management had explicitly guided that credit costs would 'normalize upwards from their recent unsustainable trough'; this quarter shows the trough persisting, which flatters the bottom line rather than validating operating momentum. Net profit margin therefore reads as expanding YoY (10.79% → 12.56%) even as operating margin compressed sharply (22.52% → 19.68%).

The stock went into the print at ₹45.3, down 4% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.

Growth and asset quality were the genuine bright spots. Gross advances rose 17% YoY to ₹1.04 lakh Cr (the Jul 1 update), running ahead of management's 15-16% FY27 loan-growth guidance; deposits grew ~11% YoY. Gross NPA improved to 1.38% from 3.15% a year ago (Net NPA 0.26% vs 0.68%) and annualised RoA held at 1.07%. No street consensus for this specific quarter was available in our records or on the web, so vsStreet is unknown. The quarter also lands amid a leadership transition: results were signed by MD & CEO PR Seshadri, while RBI on Jul 8 approved Mahesh Muralidhar Pai as the incoming MD & CEO — a continuity question for the growth-and-margin strategy going into FY27.